Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes (PROCEED)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Mario Negri Institute for Pharmacological Research
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research
ClinicalTrials.gov Identifier:
NCT01393808
First received: July 12, 2011
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)